- Lobbying
- Lobbying by MGI PHARMA, INC.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Jennifer Vesey | n/a |
Raymond Frost | n/a |
Jennifer Gruber Ms | n/a |
Raymond Frost Mr | n/a |
Jennifer Gruber Ms. | n/a |
Raymond Frost Mr. | n/a |
Feeney Robert Mr. | n/a |
Robert Feeney Mr. | n/a |
Jennifer Gruber | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Registration
Issue(s) they said they’d lobby about: Medicare and Medicaid policy and reimbursement for drugs
Prescription drug safety legislation
PDUFA reauthorization
Follow-on biologics.
MM Report
Lobbying Issues
Agencies Lobbied
Type of Issue
Lobbying Issues
Agencies Lobbied
Type of Issue
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate